Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today FDA approval of an additional claim for the cobas® Zika test for use on the cobas® 6800/8800 Systems. The newly approved claim allows for the streamlined screening of multiple individual blood or plasma donations that have been pooled together. - New claim allows for streamlined screening of pooled blood or plasma … [Read more...] about FDA approves additional claim for Roche cobas Zika test